Diabetes, Metabolic, Endocrine

We focus on ensuring appropriate endpoints are met including glycemic control, insulin management, and enhanced hormonal management.

Clinical trials in diabetes, metabolic disorders, and endocrinology play a vital role in advancing our understanding of these conditions and improving patient care. 

Common indications we have experience in include:
  • Type 1 and Type 2 Diabetes Mellitus
  • Obesity and Metabolic Syndrome
  • Thyroid and Adrenal Disorders
  • Hormone Replacement Therapy (HRT)

Pain points associated with clinical trials in diabetes, metabolic disorders and endocrinology

  • Variable Disease Progression: Diabetes, metabolic, and endocrine disorders are heterogeneous in their progression. The variable disease patterns can affect the consistency of study results.
  • Nutritional and Lifestyle Variabilities: Dietary habits, exercise routines, and other lifestyle factors play significant roles in these conditions, making it challenging to maintain consistency across participants.
  • Long-Term Monitoring and Compliance: Given the chronic nature of these conditions, trials often require long-term monitoring, which can lead to attrition and inconsistencies in treatment adherence.
  • Hormonal Fluctuations: Endocrine trials face challenges with hormonal fluctuations in participants, which can influence study outcomes.
  • Complex Medication Interactions: Many patients with these disorders are on multiple medications. Interactions between study drugs and existing medications can pose safety concerns and skew results.

How iNGENū addresses these pain points

  • Tailored Patient Segmentation: iNGENū employs stratified patient selection, ensuring participants have a similar disease progression stage, providing more consistent results.
  • Dietary and Lifestyle Standardization: We collaborate with nutritionists and lifestyle experts to create standardized guidelines for participants during the trial. This reduces variability and ensures consistency in external influences.
  • Long-Term Support and Engagement Platforms: We have developed a comprehensive patient support platform, specifically for diabetes and endocrine patients, that includes regular check-ins, reminders, and educational resources to boost long-term compliance.
  • Hormone Monitoring Protocols: Our trials in the endocrine space include rigorous hormonal monitoring, using advanced hormonal assays to account for and manage hormonal fluctuations, ensuring that they don't interfere with trial outcomes.
  • Detailed Medication Review: Before enrollment, we conduct a thorough review of a participant's medication regimen. This not only helps in selecting the right participants but also in predicting and monitoring potential drug interactions.
Ready to discuss your trial?